02.21.25 -- How Biotech Academy In Rome Is Reshaping Workforce Readiness

Join Outsourced Pharma Live for an in-depth examination on how the BIOSECURE Act is impacting risk management, compliance, and the future of global outsourcing in drug development and manufacturing. Our supply-chain experts will provide actionable insights to ensure your outsourcing strategies align with the greater legal, regulatory and geopolitical environment. Secure your free registration today!

Outsourced Pharma works with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers each month. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.

IQ, OQ, and PQ validations ensure equipment reliability, compliance, and quality in medical device and pharmaceutical manufacturing, meeting regulatory standards.

Testing for nitrosamines is essential in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and drug products to ensure safety and compliance.

Learn about how softgels are poised to facilitate innovation in the pharmaceutical industry as well as ongoing advancements in optimizing drug bioavailability through nano formulations.

In this discussion, we cover how outsourcing packaging operations is a key aspect of bringing products to market and can benefit your organization and overall supply chain optimization.

Review a commercially-ready process capable of reproducing spray-dried dispersions with less manufacturing complexity and environmental impact, and out-designing and outperforming spray drying.

Building more sustainable practices across the pharmaceutical industry takes a collaborative and transparent effort. One leading CDMO is leveraging its solvent recovery efforts to yield major strides.

Harness our decades of expertise in safe, scalable, and reliable production of APIs using advanced energetic chemistry to deliver exceptional value from development to commercialization.

Explore our global network of manufacturing sites to streamline your drug development journey with cost-effective and scalable outsourcing solutions.

As a leader in small molecule manufacturing, Ajinomoto Bio-Pharma Services has over 40 years of experience providing high-quality APIs and intermediates for companies around the world.